<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Appl Oral Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Appl Oral Sci</journal-id><journal-id journal-id-type="pmc-domain-id">2245</journal-id><journal-id journal-id-type="pmc-domain">jaos</journal-id><journal-title-group><journal-title>Journal of Applied Oral Science</journal-title></journal-title-group><issn pub-type="ppub">1678-7757</issn><issn pub-type="epub">1678-7765</issn><publisher><publisher-name>Bauru School of Dentistry</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4327221</article-id><article-id pub-id-type="pmcid-ver">PMC4327221.1</article-id><article-id pub-id-type="pmcaid">4327221</article-id><article-id pub-id-type="pmcaiid">4327221</article-id><article-id pub-id-type="pmid">19089051</article-id><article-id pub-id-type="doi">10.1590/S1678-77572006000500004</article-id><article-id pub-id-type="publisher-id">S1678-77572006000500004</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>EFFECT OF BETAMETHASONE AND DICLOFENAC SODIUM ON SERUM AND TISSUE CONCENTRATION OF AMOXICILLIN. <italic toggle="yes">In vivo</italic> STUDY IN RATS</article-title><trans-title-group xml:lang="pt"><trans-title>EFEITO DA BETAMETASONA E DO DICLOFENACO S&#211;DICO NA CONCENTRA&#199;&#195;O S&#201;RICA E TECIDUAL DA AMOXICILINA. ESTUDO in vivo EM RATOS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mattos</surname><given-names initials="TR">Thales Rocha</given-names><suffix>Filho</suffix></name><xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Junqueira</surname><given-names initials="MDS">Marcelo de Souza</given-names></name><xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Groppo</surname><given-names initials="FC">Francisco Carlos</given-names></name><xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Motta</surname><given-names initials="RHL">Rog&#233;rio Hel&#225;dio Lopes</given-names></name><xref ref-type="aff" rid="aff02">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Perazzo</surname><given-names initials="FF">F&#225;bio Ferreira</given-names></name><xref ref-type="aff" rid="aff03">
<sup>3</sup>
</xref></contrib><aff id="aff01"><label>1</label>DDS. MSc, PhD, Department of Pharmacology, Anesthesiology and Therapeutics, Piracicaba Dental School - UNICAMP, SP, Brazil</aff><aff id="aff02"><label>2</label>DDS, MSc, PhD, Department of Pharmacology, Anesthesiology and Therapeutics, S&#227;o Leopoldo Mandic Dental School, Campinas, SP, Brazil</aff><aff id="aff03"><label>3</label>Pharm, MSc, PhD, Pharmacy Laboratory, University Campi "Marco Zero do Equador" Macap&#225;, AP, Brazil</aff></contrib-group><author-notes><corresp id="c01"><bold>Corresponding address:</bold> Prof. Dr. Francisco Carlos Groppo, Av Limeira 901, Bairro Arei&#227;o - Piracicaba, S&#227;o Paulo, Brazil - ZIP 13414-903 - Tel: <phone>19 3412-5310</phone> - Fax: <fax>19 3421-0144</fax> e-mail: <email>fcgroppo@fop.unicamp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>10</month><year>2006</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2006</year></pub-date><volume>14</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">249341</issue-id><fpage>319</fpage><lpage>323</lpage><history><date date-type="received"><day>01</day><month>7</month><year>2005</year></date><date date-type="rev-recd"><day>10</day><month>4</month><year>2006</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2006</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2006</year></date></event><event event-type="pmc-live"><date><day>16</day><month>04</month><year>2015</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2015-04-17 00:07:35.487"><day>17</day><month>04</month><year>2015</year></date></event></pub-history><permissions><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1678-7757-jaos-14-05-0319.pdf"/><abstract><sec><title>Objective:</title><p>Antimicrobial agents in combination with anti-inflammatory drugs have been usually prescribed in both Medicine and Dentistry. However, few scientific reports support this clinical practice. The aim of this study was to evaluate the effect of betamethasone and diclofenac sodium on serum and tissue concentration of amoxicillin in rats.</p></sec><sec><title>Methods:</title><p>Four polyurethane sponges were implanted in the back skin of 48 rats. After seven days the animals were divided into 6 groups (n=8). Group 1: amoxicillin (25 mg/kg); G2: diclofenac sodium (2.5 mg/kg); G3: betamethasone (0.1 mg/kg); G4: diclofenac sodium and amoxicillin; G5: betamethasone and amoxicillin; and G6: 0.9% sodium chloride solution (1.0 mL - control group). All drugs were administered in a single dose. After 90 minutes, the granulomatous tissues of each animal were surgically removed and weighed. Blood was collected from cervical plexus, centrifuged and 10&#956;L of serum was placed on paper discs. In order to estimate amoxicillin concentration, serum and granulomatous tissues were separately submitted to microbiological assay, which used 10<sup>8</sup>cfu/mL of Staphylococcus aureus ATCC 25923 (penicillin-susceptible strain). After incubation (18 hours, 37&#176;C) the inhibition zones were measured and compared to a regression curve.</p></sec><sec><title>Results:</title><p>No inhibition zones were observed for groups 2, 3 and 6. Tissue and serum concentrations of both G1 (4.14&#956;g/g and 2.06&#956;g/mL, respectively) and G5 (3.87&#956;g/g and 1.70&#956;g/mL, respectively) showed statistically significant differences (Kruskal-Wallis, p&lt;0.05) in comparison to G4 (1.45&#956;g/g and 0.41&#956;g/mL, respectively). G1 and G5 did not differ significantly (p&gt;0.05).</p></sec><sec><title>Conclusion:</title><p>Considering single doses, betamethasone did not interfere with amoxicillin levels but diclofenac sodium reduced both tissue and serum levels of amoxicillin in rats.</p></sec></abstract><trans-abstract xml:lang="pt"><sec><title>Objetivo:</title><p>A prescri&#231;&#227;o de antimicrobianos associados a antiinflamat&#243;rios &#233; uma pr&#225;tica comum em odontologia, embora na maioria das vezes n&#227;o haja justificativa para tal conduta. O objetivo deste trabalho foi avaliar, em um estudo in vivo em ratos, os efeitos da betametasona e do diclofenaco s&#243;dico nas concentra&#231;&#245;es s&#233;rica e tecidual da amoxicilina.</p></sec><sec><title>M&#233;todos:</title><p>Foram utilizados 48 ratos Wistar machos (6 grupos, n=8), com idade de 60 dias. Esponjas de PVC (policlorovinil) foram implantadas em quatro pontos no dorso de cada animal. Ap&#243;s sete dias, foram administrados por via intrag&#225;strica ou intramuscular: Grupo 1: amoxicilina (25 mg/kg); G2: diclofenaco s&#243;dico (2,5 mg/kg/i.m.); G3: betametasona (0,1 mg/kg/i.m.); G4: diclofenaco s&#243;dico e amoxicilina; G5: betametasona e amoxicilina; e G6: solu&#231;&#227;o de cloreto de s&#243;dio a 0,9% (1,0 mL &#8211; grupo controle). Ap&#243;s 90 minutos, foram colhidos 2 tecidos granulomatosos e amostras s&#233;ricas de cada animal e colocados em meios de cultura inoculados com 10<sup>8</sup> ufc/mL de Staphylococcus aureus ATCC 25923. Os halos de inibi&#231;&#227;o foram medidos ap&#243;s 18 horas de incuba&#231;&#227;o (37&#176;C), e atrav&#233;s do teste microbiol&#243;gico foram obtidas as concentra&#231;&#245;es s&#233;ricas e teciduais da amoxicilina.</p></sec><sec><title>Resultados:</title><p>N&#227;o foram observados halos de inibi&#231;&#227;o para os grupos 2, 3 e 6. As concentra&#231;&#245;es s&#233;ricas e teciduais de G1 (4,14&#956;g/g e 2,06&#956;g/mL, respectivamente) e G5 (3,87&#956;g/g e 1,70&#956;g/mL, respectivamente) demonstraram diferen&#231;as estatisticamente significantes (Kruskal-Wallis, p&lt;0,05) em compara&#231;&#227;o a G4 (1,45&#956;g/g e 0,41&#956;g/mL, respectivamente). G1 e G5 n&#227;o apresentaram diferen&#231;a estat&#237;stica (p&gt;0,05).</p></sec><sec><title>Conclus&#227;o:</title><p>Considerando uma dose &#250;nica, a betametasona n&#227;o interferiu nas concentra&#231;&#245;es s&#233;rica e tecidual de amoxicilina, enquanto o diclofenaco s&#243;dico reduziu as concentra&#231;&#245;es s&#233;rica e tecidual de amoxicilina em ratos.</p></sec></trans-abstract><kwd-group><kwd>Amoxicillin</kwd><kwd>Betamethasone</kwd><kwd>Drug interaction</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="31"/><page-count count="5"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Amoxicillin is a widely prescribed aminopenicillin, primarily for oral use<xref rid="B22" ref-type="bibr">22</xref>. It has been used as the first choice in several odontogenic infections and bacterial endocarditis prophylaxis. The standard bacterial endocarditis prophylaxis regimen includes a 2-g single dose of amoxicillin, one hour before the procedure<xref rid="B07" ref-type="bibr">7</xref>.</p><p>The oral daily recommended dosage for adult patients is usually 250 to 500mg TID<xref rid="B09" ref-type="bibr">9</xref> or 875 to 1000mg BID<xref rid="B04" ref-type="bibr">4</xref>. For pediatric patients, depending on the infection severity and the etiological agent, the dosage is usually 25 to 50mg/kg TID<xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B08" ref-type="bibr">8</xref>.</p><p>Amoxicillin has been also frequently used in Dentistry as a substitute for phenoxymethylpenicillin and ampicillin due to a better oral absorption and larger period of time between doses. Food does not interfere with either absorption or plasma concentration of amoxicillin<xref rid="B06" ref-type="bibr">6</xref>.</p><p>Ninety percent of the administered dose of amoxicillin is absorbed without molecular modifications<xref rid="B13" ref-type="bibr">13</xref> providing serum concentration ranging from 7.6 &#956;g/mL to 10.8 &#956;g/mL after 500 mg/po dose in human beings<xref rid="B10" ref-type="bibr">10</xref>. In rats, serum concentration ranged from 28&#956;g/mL and 13&#956;g/mL when 40 mg/kg/po and 7.0 mg/kg/po of amoxicillin were administered, respectively<xref rid="B03" ref-type="bibr">3</xref>,<xref rid="B11" ref-type="bibr">11</xref>.</p><p>Approximately 60% of oral doses of amoxicillin are excreted in the urine in unchanged form within six hours by glomerular filtration (to a limited extent) and tubular secretion<xref rid="B16" ref-type="bibr">16</xref>. PEPT1 (in intestine) and PEPT2 (in kidney) are H+-coupled peptide transporters that mediate and limit the transport of amoxicillin<xref rid="B27" ref-type="bibr">27</xref>. Other drugs that have affinity for these transporters could interfere with amoxicillin bioavailability.</p><p>Antimicrobial agents help the host immune system to kill bacteria. The phagocytic cells are a major component of host resistance against bacteria and any drug that impairs their function is likely to increase susceptibility to infection<xref rid="B21" ref-type="bibr">21</xref>. However, the modulation of the inflammatory response of infectious diseases could be beneficial since the sequelae relate, in part, to this reaction<xref rid="B23" ref-type="bibr">23</xref>.</p><p>The association of antimicrobial and anti-inflammatory agents is relatively common in Dentistry and in Medicine. This association has been used routinely for prevention of infection along with the use of corticosteroids, for example. However, there are few studies regarding the effects of this association<xref rid="B02" ref-type="bibr">2</xref>.</p><p>Dexamethasone has been used together with different antibiotics in the treatment of experimental staphylococcal endophthalmitis<xref rid="B31" ref-type="bibr">31</xref>, and septic nephritis<xref rid="B29" ref-type="bibr">29</xref>. Siaperas, et al.<xref rid="B25" ref-type="bibr">25</xref> (2001) observed that dexamethasone (0.5 mg/kg, BID) used together with vancomycin (30mg/kg every 12 h, IV) reduced the tissue damage of the aortic valves in experimental staphylococcal endocarditis and did not affect the antimicrobial agent effectiveness.</p><p>In a rat model, the combination therapy with antibiotics and steroids was also more effective to reduce, or even to prevent, the persistence of ear mucosal changes in acute otitis media than the administration of antibiotics alone<xref rid="B19" ref-type="bibr">19</xref>.</p><p>However, one of the main side effects of anti-inflammatory drugs, particularly corticosteroids, is the impairment of cellular defenses against infection. The reactivation of latent infections by corticosteroids has proven to be a clinical problem<xref rid="B21" ref-type="bibr">21</xref>.</p><p>Non-steroidal anti-inflammatory drugs do not prevent the synthesis of leukotriene B4 (a potent endogenous chemotactic factor), which could explain why therapeutic doses of aspirin-like drugs have little or no effect on leukocyte accumulation and activation during the inflammatory phenomenon<xref rid="B21" ref-type="bibr">21</xref>. As well as corticosteroids, there are very few studies about the concomitant use of these anti-inflammatory drugs and antimicrobial agents.</p><p>Drug interactions between amoxicillin and diclofenac sodium were previously demonstrated in the literature<xref rid="B12" ref-type="bibr">12</xref>. This study showed that both amoxicillin tissue and serum concentrations were significantly reduced by diclofenac sodium.</p><p>Being the corticosteroids one of the most used antiinflammatory agents in dentistry when a significant amount of surgical trauma is expected<xref rid="B02" ref-type="bibr">2</xref>, the purpose of this study was to verify the effect of betamethasone on serum and tissue concentrations of amoxicillin.</p></sec><sec sec-type="materials|methods"><title>MATERIAL AND METHODS</title><sec><title>Bacterial strain</title><p>A penicillin-sensible <italic toggle="yes">Staphylococcus aureus</italic> strain (ATCC 25923) was used for the <italic toggle="yes">in-vitro</italic> test to determine the MIC and MBC<sub>100</sub> by using Mueller-Hinton broth (Merck, Darnstadt, Germany) and Salt Mannitol agar (Merck, Darnstadt, Germany), respectively. The same strain was used to carry out the regression line assay and the microbiological assay of amoxicillin concentrations.</p></sec><sec><title>Drugs</title><p>Amoxicillin trihydrate was obtained from Sigma Chemical Co. (St Louis, MO, U.S.A.). Betamethasone (Celestone injectable&#174; &#8211; Schering-Plough S/A) and diclofenac sodium (Voltaren injectable&#174; &#8211; Novartis Bioci&#234;ncias) were commercially obtained. Physiological saline solution (0.9% NaCl) was administered to the control animals.</p></sec><sec><title>Animals</title><p>Forty-eight adult male <italic toggle="yes">Wistar</italic> rats <italic toggle="yes">(Rattus norvegicus</italic>- albinus), aged 60 days and weighing 175&#177;25g, were obtained from CEMIB-UNICAMP (Centro de Bioterismo-ICLAS Monitoring/Reference Center, Campinas, Brazil) where they were maintained under aseptic conditions. The Institutional Review Board for Ethics in Animal Research of University of Campinas approved all procedures (protocol #423-1).</p></sec><sec><title>Granulomatous tissue model</title><p>All animals were anesthetized with a combination of ketamine 90 mg/kg/i.m., and xylazine 10 mg/kg/i.m.<xref rid="B28" ref-type="bibr">28</xref> and granulomatous tissue was induced as previously described<xref rid="B03" ref-type="bibr">3</xref>,<xref rid="B12" ref-type="bibr">12</xref>. Briefly, four sterilized polyurethane sponge discs (density 35 kg/m<sup>3</sup>) were subcutaneously implanted in the back of all rats. These sponge discs (Proespuma Com. &amp; Ind. Ltd., S&#227;o Paulo, Brazil) were 12 mm in diameter and 5 mm thick, weighing 12.1&#177;0.81mg.</p></sec><sec><title>Experimental groups</title><p>Seven days after the sponge introduction, all animals were assigned into six groups of eight animals each: G1 &#8211; amoxicillin 25 mg/kg/p.o.; G2 &#8211; diclofenac sodium 2.5 mg/kg/i.m.; G3 &#8211; betamethasone 0.1 mg/kg/i.m.; G4 &#8211; amoxicillin 25 mg/kg/p.o. and diclofenac sodium 2.5 mg/kg/i.m.; G5 &#8211; amoxicillin 25 mg/kg/p.o. and betamethasone 0.1 mg/kg/i.m.; and G6 &#8211; physiological saline (0.9% NaCl) 1.0 mL/p.o. All drugs were administered in a single dose.</p></sec><sec><title>Surgical and sampling procedures</title><p>After 90min of drug administration, blood samples were collected by cutting the carotid plexus of each animal under general anesthesia.</p><p>Blood samples were centrifuged and 10&#956;L of serum was placed on three sterilized paper discs (6.25mm) and dried at room temperature. Granulomatous tissues were delimited and surgically removed. All discs and two granulomatous tissue samples of each animal were placed on Muller-Hinton Agar plates inoculated with 10<xref rid="B08" ref-type="bibr">8</xref> cfu/mL of <italic toggle="yes">S. aureus</italic>. After 18 hours of incubation at 37&#176;C, the inhibition zones were measured. Two granulomatous tissue samples of each animal were weighed and analyzed by a histological routine technique (HE). Granulomatous tissue weights, tissue and serum concentrations were submitted to the Kruskal-Wallis test and Dunn test (software Bioestat 1.0&#174; for Windows&#169;) in order to compare all groups.</p></sec><sec><title>Regression line</title><p>Amoxicillin suspensions of 0.03, 0.05, 0.07, 0.10, 0.30, 0.50, 0.70, 1.0, 3.0, 5.0, 7.0 and 10&#956;g/mL were made by using drug-free serum of rats and 10 &#956;L were placed onto dry paper-filter discs (6.25 mm). Three discs of each concentration were placed on the Mueller Hinton agar, previously inoculated with 10<xref rid="B08" ref-type="bibr">8</xref> cfu/mL of <italic toggle="yes">S. aureus</italic>. The resulting inhibition zones were measured (mm) after 18 hours of incubation at 37&#176;C. These zones and the amoxicillin concentrations were used to obtain the regression line (Excel XP&#174; &#8211; Microsoft Corporation).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>MIC and MBC<sub>100</sub> of amoxicillin against <italic toggle="yes">S. aureus</italic> ATCC 25923 were respectively 0.2&#956;g/mL and 1.5&#956;g/mL.</p><p>The limits of detection of the regression curve were 0.03&#956;g/mL (12 mm of inhibition zone diameter) and 10&#956;g/mL (31 mm of inhibition zone diameter). The relation between the diameter of inhibition zone (DIZ &#8211; in mm) and the concentration of amoxicillin (CA &#8211; in &#956;g/mL) was DIZ = (3.23 x Ln (CA)) + 24.16, which showed a coefficient of regression (R) of 0.9851. This relation was used to estimate tissue and serum concentrations, considering the mean of tissue weights of each animal.</p><p>The wet weight (mg) values (mean &#177; s.e.m.) of the granulomatous tissue samples were 30.25 (&#177; 1.98), 42.81 (&#177; 3.26), 40.25 (&#177; 1.98), 31.25 (&#177; 2.58), 46.5 (&#177; 3.8) and 41.19 (&#177; 2.22), respectively for groups 1, 2, 3, 4, 5 and 6. No statistically significant differences were observed among groups (p&gt;0.05) regarding the wet weight values.</p><p>After 7 days and 90 minutes, a delimited fibrous capsule involving the sponge was observed in all samples. Fibroblasts, mesenchymal cells, and new capillary formation were verified in large scale. Infectious exudate was not observed in any of the granulomatous tissues.</p><p>
<xref ref-type="fig" rid="f01">Figure 1</xref> shows amoxicillin serum and tissue concentrations of groups 1, 4 and 5. Groups 2, 3 and 6 did not show any inhibition zone considering both serum and tissue samples during the microbiological assay. Just the groups that used amoxicillin showed these inhibition zones. Amoxicillin serum and tissue concentration were not significantly (p&gt;0.05) affected by betamethasone. However, diclofenac sodium induced a reduction in both serum and tissue amoxicillin concentrations (p&lt;0.05).</p><fig id="f01" orientation="portrait" position="float"><label>FIGURE 1</label><caption><title>Amoxicillin serum and tissue concentrations (mean &#177; s.e.m.) considering groups 1, 4 and 5. Groups 2, 3 and 6 did not show any inhibition zone considering both serum and tissue samples. Different letters mean statistically significant differences (p&lt;0.05) among groups, considering serum and tissue concentrations separately</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1678-7757-jaos-14-05-0319-gf01.jpg"/></fig></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>MIC and MBC<sub>100</sub> of amoxicillin against <italic toggle="yes">S. aureus</italic> ATCC 25923 strain confirmed its susceptibility<xref rid="B14" ref-type="bibr">14</xref>. As observed in previous studies, the microbiological method was accurate enough to measure amoxicillin concentrations in this study<xref rid="B12" ref-type="bibr">12</xref>. This method has the same precision as HPLC assay<xref rid="B17" ref-type="bibr">17</xref> and it has been widely used for determining amoxicillin concentration<xref rid="B05" ref-type="bibr">5</xref>.</p><p>According to Groppo, et al.<xref rid="B12" ref-type="bibr">12</xref> (2000), the period of 7 days used for the development of granulomatous tissue in the present study is adequate. These authors observed that different periods (7, 14, 21 and 28 days) for development of granulomatous tissues in rats did not interfere with the pharmacokinetics of amoxicillin.</p><p>The high anti-inflammatory activity of betamethasone and diclofenac sodium in both humans<xref rid="B02" ref-type="bibr">2</xref> and rats<xref rid="B24" ref-type="bibr">24</xref> was previously demonstrated. However, both anti-inflammatory agents with or without amoxicillin were unable to reduce tissue wet weights in the present model. Probably, the chosen model, i.e., chronic inflammatory granulomatous tissue, was not adequate to study anti-inflammatory properties. In addition, a single dose could not be enough to significantly reduce the inflammatory cells reflecting in a lower wet weight of the granulomatous tissues.</p><p>Another factor that could contribute to this nonsignificant anti-inflammatory activity is time. A previous study<xref rid="B11" ref-type="bibr">11</xref> showed a significant reduction in the wet weight of granulomatous tissues in rats after six hours of diclofenac sodium administration (2.5 mg/kg/i.m.) and probably 90 minutes (used at the present study) was not enough to observe significant reduction in wet weight.</p><p>The results of the present study corroborate with previous findings<xref rid="B12" ref-type="bibr">12</xref> that showed great reduction in serum and tissue amoxicillin concentrations caused by diclofenac sodium. These authors observed that the drug interaction was probably not caused by metabolism or excretion interferences, since amoxicillin and diclofenac have different pharmacokinetics (plasmatic protein binding, excretion and metabolism). These same considerations about diclofenac could be applied to betamethasone.</p><p>In the present study, betamethasone did not interfere with serum or tissue concentration of amoxicillin when compared with the group in which amoxicillin was administered alone. This finding is important since the serum concentration of amoxicillin must be clinically significant considering prophylactic use of this antimicrobial agent<xref rid="B02" ref-type="bibr">2</xref>.</p><p>While amoxicillin has intestinal absorption through passive diffusion<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B26" ref-type="bibr">26</xref> and through oligopeptide transporter system present mainly in kidney and intestine<xref rid="B18" ref-type="bibr">18</xref> the absorption of diclofenac occurs mainly through excretion in the bile<xref rid="B20" ref-type="bibr">20</xref>. There are no data regarding the association between peptide transporters and diclofenac absorption. However, other drugs that have a high affinity for peptide transporters, like amiloride<xref rid="B30" ref-type="bibr">30</xref> caused high decreases in amoxicillin concentration.</p><p>Thus, diclofenac could cause a reduction in the amoxicillin absorption. Steroidal agents were not associated with the same oligopeptide transporter system that is responsible for amoxicillin absorption<xref rid="B18" ref-type="bibr">18</xref>, which could explain the absence of drug interactions between both agents.</p><p>It was concluded that betamethasone did not affect the serum and tissue amoxicillin concentrations but diclofenac sodium significantly reduced them.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>The authors thank CAPES for financial support and Mr. Jorge Val&#233;rio for his assistance in the manuscript preparation.</p></ack><ref-list><title>REFERENCES</title><ref id="B01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>G</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>S</given-names></name><name name-style="western"><surname>Kabra</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>A</given-names></name><name name-style="western"><surname>Singhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Walter</surname><given-names>SD</given-names></name></person-group><article-title>Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial</article-title><source>BMJ</source><year>2004</year><volume>328</volume><fpage>791</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">15070633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.38049.490255.DE</pub-id><pub-id pub-id-type="pmcid">PMC383371</pub-id></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>RE</given-names></name><name name-style="western"><surname>Throndson</surname><given-names>RR</given-names></name></person-group><article-title>A review of perioperative corticosteroid use in dentoalveolar surgery</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2000</year><volume>90</volume><fpage>406</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">11027375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/moe.2000.109778</pub-id></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baglie</surname><given-names>S</given-names></name><name name-style="western"><surname>Groppo</surname><given-names>FC</given-names></name><name name-style="western"><surname>Mattos</surname><given-names>TR</given-names><suffix>Filho</suffix></name></person-group><article-title>Tissue pharmacokinetic of amoxicillin. An experimental design in rats</article-title><source>Braz J Infect Dis</source><year>2000</year><volume>4</volume><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">11008224</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bantar</surname><given-names>C</given-names></name><name name-style="western"><surname>Nicola</surname><given-names>F</given-names></name><name name-style="western"><surname>Fernandez Canigia</surname><given-names>L</given-names></name><name name-style="western"><surname>Arenoso</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Soutric</surname><given-names>J</given-names></name><name name-style="western"><surname>Montoto</surname><given-names>M</given-names></name><etal/></person-group><article-title>A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections</article-title><source>J Chemother</source><year>2000</year><volume>12</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">10877517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/joc.2000.12.3.223</pub-id></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charles</surname><given-names>BG</given-names></name><name name-style="western"><surname>Chulavatnatol</surname><given-names>S</given-names></name></person-group><article-title>Simple analysis of amoxicillin in plasma by high performance liquid chromatography whit internal standardization and ultraviolet detection</article-title><source>Biomed Chromatogr</source><year>1993</year><volume>7</volume><fpage>204</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">8219698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bmc.1130070407</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dajani</surname><given-names>AS</given-names></name><name name-style="western"><surname>Bawdon</surname><given-names>RE</given-names></name><name name-style="western"><surname>Berry</surname><given-names>MC</given-names></name></person-group><article-title>Oral Amoxicillin as prophylaxis for endocarditis: what is the optimal dose?</article-title><source>Clin Infect Dis</source><year>1994</year><volume>18</volume><fpage>157</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">8161620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/clinids/18.2.157</pub-id></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dajani</surname><given-names>AS</given-names></name><name name-style="western"><surname>Taubert</surname><given-names>KA</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>W</given-names></name><name name-style="western"><surname>Bolger</surname><given-names>AF</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferrieri</surname><given-names>P</given-names></name><etal/></person-group><article-title>Prevention of bacterial endocarditis: recommendations by the American Heart Association</article-title><source>J Am Dent Assoc</source><year>1997</year><volume>128</volume><fpage>1142</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">9260427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14219/jada.archive.1997.0375</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garbutt</surname><given-names>JM</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Gellman</surname><given-names>E</given-names></name><name name-style="western"><surname>Shannon</surname><given-names>W</given-names></name><name name-style="western"><surname>Littenberg</surname><given-names>B</given-names></name></person-group><article-title>A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis</article-title><source>Pediatrics</source><year>2001</year><volume>107</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">11335733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.107.4.619</pub-id></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgopoulos</surname><given-names>A</given-names></name><name name-style="western"><surname>Borek</surname><given-names>M</given-names></name><name name-style="western"><surname>Ridl</surname><given-names>W</given-names></name></person-group><article-title>Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis</article-title><source>J Antimicrob Chemother</source><year>2001</year><volume>47</volume><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">11152433</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/47.1.67</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>RC</given-names></name><name name-style="western"><surname>Regamey</surname><given-names>C</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>WMN</given-names></name></person-group><article-title>Comparative clinical pharmacology of amoxicillin and ampicillin administered orally</article-title><source>Antimicrob Agents Chemother</source><year>1972</year><volume>1</volume><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">4680813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.1.6.504</pub-id><pub-id pub-id-type="pmcid">PMC444250</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groppo</surname><given-names>FC</given-names></name><name name-style="western"><surname>Mattos</surname><given-names>TR</given-names><suffix>Filho</suffix></name><name name-style="western"><surname>Del-Fiol</surname><given-names>FS</given-names></name></person-group><article-title>Bioassay of amoxicillin in rats</article-title><source>Biol Pharm Bull</source><year>2000</year><volume>23</volume><fpage>1033</fpage><lpage>1035</lpage><pub-id pub-id-type="pmid">10993199</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/bpb.23.1033</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groppo</surname><given-names>FC</given-names></name><name name-style="western"><surname>Sim&#245;es</surname><given-names>RP</given-names></name><name name-style="western"><surname>Ramacciato</surname><given-names>JC</given-names></name><name name-style="western"><surname>Rehder</surname><given-names>V</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>ED</given-names></name><name name-style="western"><surname>Mattos</surname><given-names>TR</given-names><suffix>Filho</suffix></name></person-group><article-title>Effect of sodium diclofenac on serum and tissue concentration of amoxicillin and on staphylococcal infection</article-title><source>Biol Pharm Bull</source><year>2004</year><volume>27</volume><fpage>52</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">14709898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/bpb.27.52</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huisman-de-Boer</surname><given-names>JJ</given-names></name><name name-style="western"><surname>van den Anker</surname><given-names>JN</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>M</given-names></name><name name-style="western"><surname>Goessens</surname><given-names>WH</given-names></name><name name-style="western"><surname>Schoemaker</surname><given-names>RC</given-names></name><name name-style="western"><surname>Groot</surname><given-names>R</given-names></name></person-group><article-title>Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks</article-title><source>Antimicrob Agents Chemother</source><year>1995</year><volume>39</volume><fpage>431</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">7726510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.39.2.431</pub-id><pub-id pub-id-type="pmcid">PMC162555</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Koneman</surname><given-names>EW</given-names></name><name name-style="western"><surname>Allen</surname><given-names>SD</given-names></name><name name-style="western"><surname>Janda</surname><given-names>WM</given-names></name><name name-style="western"><surname>Schreckenberger</surname><given-names>PC</given-names></name><name name-style="western"><surname>Winn</surname><given-names>WC</given-names><suffix>Jr</suffix></name></person-group><source>Color atlas and textbook of diagnostic microbiology</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>J.B. Lippincott Company</publisher-name><year>1997</year></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margarit</surname><given-names>F</given-names></name><name name-style="western"><surname>Moreno-Dalmau</surname><given-names>J</given-names></name><name name-style="western"><surname>Obach</surname><given-names>R</given-names></name><name name-style="western"><surname>Peraire</surname><given-names>C</given-names></name><name name-style="western"><surname>Pla-Delfina</surname><given-names>JM</given-names></name></person-group><article-title>Intestinal absorption kinetics of a series of aminopenicillins and azidocillin. A comparative study in the rat</article-title><source>Eur J Drug Metab Pharmacokinet</source><year>1991</year><volume>3</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">1820862</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Martindale</surname><given-names>W</given-names></name></person-group><source>The Extra Pharmacopoeia</source><edition>31th ed.</edition><publisher-loc>London</publisher-loc><publisher-name>Royal Pharmaceutical Society Press</publisher-name><year>1996</year><fpage>125</fpage><lpage>129</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>TD</given-names></name><name name-style="western"><surname>Horton</surname><given-names>R</given-names></name><name name-style="western"><surname>Utrup</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>LA</given-names></name><name name-style="western"><surname>Poupard</surname><given-names>JA</given-names></name></person-group><article-title>Stability of amoxicilin-clavulanate in bactec medium determined by high-performance liquid chromatography and bioassay</article-title><source>J Clin Microbiol</source><year>1996</year><volume>34</volume><fpage>1321</fpage><lpage>1322</lpage><pub-id pub-id-type="pmid">8727931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.34.5.1321-1322.1996</pub-id><pub-id pub-id-type="pmcid">PMC229010</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>VA</given-names></name><name name-style="western"><surname>Irwin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Timmins</surname><given-names>P</given-names></name><name name-style="western"><surname>Chong</surname><given-names>S</given-names></name><name name-style="western"><surname>Dando</surname><given-names>SA</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>RA</given-names></name></person-group><article-title>A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterization</article-title><source>Int J Pharm</source><year>2000</year><volume>210</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">11163984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-5173(00)00563-9</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SN</given-names></name><name name-style="western"><surname>Yeo</surname><given-names>SW</given-names></name></person-group><article-title>Effects of antibiotics and steroid on middle ear mucosa in rats with experimental acute otitis media</article-title><source>Acta Otolaryngol</source><year>2001</year><volume>121</volume><fpage>808</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">11718243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00016480152602249</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peris-Ribera</surname><given-names>JE</given-names></name><name name-style="western"><surname>Torres-Molina</surname><given-names>F</given-names></name><name name-style="western"><surname>Garcia-Carbonell</surname><given-names>MC</given-names></name><name name-style="western"><surname>Aristorena</surname><given-names>JC</given-names></name><name name-style="western"><surname>Pla-Delfina</surname><given-names>JM</given-names></name></person-group><article-title>Pharmacokinetics and bioavailability of diclofenac in the rat</article-title><source>J Pharmacokinet Biopharm</source><year>1991</year><volume>19</volume><fpage>647</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">1815046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF01080872</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plant</surname><given-names>JE</given-names></name><name name-style="western"><surname>Higgs</surname><given-names>GA</given-names></name><name name-style="western"><surname>Easmon</surname><given-names>CSF</given-names></name></person-group><article-title>Effects of anti-inflammatory agents on chronic Salmonella typhimurium infection in a mouse model</article-title><source>Infect Immun</source><year>1983</year><volume>42</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">6413416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.42.1.71-75.1983</pub-id><pub-id pub-id-type="pmcid">PMC264525</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prevot</surname><given-names>MH</given-names></name><name name-style="western"><surname>Jehl</surname><given-names>F</given-names></name><name name-style="western"><surname>Rouveix</surname><given-names>B</given-names></name></person-group><article-title>Pharmacokinetics of a new oral formulation of amoxicillin</article-title><source>Eur J Drug Metab Pharmacokinet</source><year>1997</year><volume>22</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">9179560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF03189784</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>AF</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>SL</given-names></name><name name-style="western"><surname>Hawkins</surname><given-names>EP</given-names></name><name name-style="western"><surname>Mason</surname><given-names>E</given-names><suffix>Jr</suffix></name></person-group><article-title>Effect of dexamethasone or hwa-138 in combination with antibiotics in experimental haemophilus influenzae type b infection</article-title><source>Antimicrob Agents Chemother</source><year>1991</year><volume>35</volume><fpage>1980</fpage><lpage>1984</lpage><pub-id pub-id-type="pmid">1759817</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.35.10.1980</pub-id><pub-id pub-id-type="pmcid">PMC245311</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholer</surname><given-names>DW</given-names></name><name name-style="western"><surname>Ku</surname><given-names>EC</given-names></name><name name-style="western"><surname>Boettcher</surname><given-names>I</given-names></name><name name-style="western"><surname>Schweizer</surname><given-names>A</given-names></name></person-group><article-title>Pharmacology of diclofenac sodium</article-title><source>Am J Med</source><year>1986</year><volume>80</volume><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">3085490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(86)90077-x</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siaperas</surname><given-names>P</given-names></name><name name-style="western"><surname>Pefanis</surname><given-names>A</given-names></name><name name-style="western"><surname>Iliopoulos</surname><given-names>D</given-names></name><name name-style="western"><surname>Katsarolis</surname><given-names>I</given-names></name><name name-style="western"><surname>Kyroudi-Voulgari</surname><given-names>A</given-names></name><name name-style="western"><surname>Donta</surname><given-names>I</given-names></name><etal/></person-group><article-title>Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><fpage>3531</fpage><lpage>3537</lpage><pub-id pub-id-type="pmid">11709335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.45.12.3531-3537.2001</pub-id><pub-id pub-id-type="pmcid">PMC90864</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugawara</surname><given-names>M</given-names></name><name name-style="western"><surname>Saitoh</surname><given-names>H</given-names></name><name name-style="western"><surname>Iseki</surname><given-names>K</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Arita</surname><given-names>T</given-names></name></person-group><article-title>Contribution of passive transport mechanisms to the intestinal absorption of betalactam antibiotics</article-title><source>J Pharm Pharmacol</source><year>1989</year><volume>42</volume><fpage>314</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">1976777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.2042-7158.1990.tb05418.x</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terada</surname><given-names>T</given-names></name><name name-style="western"><surname>Saito</surname><given-names>H</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>M</given-names></name><name name-style="western"><surname>Inui</surname><given-names>KI</given-names></name></person-group><article-title>Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLCPK1cells</article-title><source>Am J Physiol</source><year>1997</year><volume>273</volume><fpage>706</fpage><lpage>711</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.1997.273.5.F706</pub-id><pub-id pub-id-type="pmid">9374833</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Pelt</surname><given-names>LF</given-names></name></person-group><article-title>Ketamine and xylazine for surgical anesthesia in rats</article-title><source>J Am Vet Med Assoc</source><year>1977</year><volume>171</volume><fpage>842</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">924855</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verba</surname><given-names>V</given-names></name><name name-style="western"><surname>Sakiniene</surname><given-names>E</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A</given-names></name></person-group><article-title>Beneficial effect of glucocorticoids on the course of haematogenously acquired Staphylococcus aureus nephritis</article-title><source>Scand J Immunol</source><year>1997</year><volume>45</volume><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">9122618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-3083.1997.d01-400.x</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westphal</surname><given-names>JF</given-names></name><name name-style="western"><surname>Brogard</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jehl</surname><given-names>F</given-names></name><name name-style="western"><surname>Carbon</surname><given-names>C</given-names></name></person-group><article-title>Assessment of the role of enterocyte ion exchange in the intestinal absorption of amoxicillin, based on a study of the interaction with amiloride</article-title><source>Pathol Biol</source><year>1995</year><volume>43</volume><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="pmid">8570263</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshizumi</surname><given-names>OM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>GC</given-names></name><name name-style="western"><surname>Equi</surname><given-names>RA</given-names></name><name name-style="western"><surname>Kim</surname><given-names>IT</given-names></name><name name-style="western"><surname>Pitchekian-Halabi</surname><given-names>H</given-names></name><name name-style="western"><surname>Adamu</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis</article-title><source>Retina</source><year>1998</year><volume>18</volume><fpage>130</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">9564693</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006982-199818020-00006</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>